Literature DB >> 18974124

Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.

Marc T Goodman1, Yurii B Shvetsov, Katharine McDuffie, Lynne R Wilkens, Xuemei Zhu, Pamela J Thompson, Lily Ning, Jeffrey Killeen, Lori Kamemoto, Brenda Y Hernandez.   

Abstract

Few natural history studies of cervical human papillomavirus (HPV) incidence and duration have been conducted among older women, especially from multiethnic populations. Viral and nonviral determinants of HPV acquisition and clearance were examined among 972 sexually active women, ages 18 to 85 years, recruited from clinics on Oahu, Hawaii, and followed for a mean duration of 15 months (range, 2-56 months). Interviews and cervical cell specimens for cytology and HPV DNA detection by PCR, using the PGMY09/PGMY11 primer system, were obtained at baseline and at 4-month intervals. The prevalence of cervical HPV infection was 25.6% at study entry. A total of 476 incident genotype-specific infections were observed during the follow-up period. The incidence of high-risk (HR) HPV types (9.26 per 1,000 woman-months) was similar to low-risk (LR) HPV types (8.24 per 1,000 woman-months). The most commonly acquired HR-HPV types were HPV-52, HPV-16, and HPV-31; and their incidence was increased significantly with a coexisting cervical HPV infection. Cervical HPV acquisition decreased with age, income, and long-term use of oral contraceptives and increased with number of sexual partners, use of hormonal creams, alcohol drinking, and condom use by a sexual partner. Cohort participants cleared 265 of the 476 incident infections during follow-up. LR-HPV infections cleared more rapidly than did HR-HPV infections (median, 180 days versus 224 days). Clearance times were enhanced among older women and women with multiple infections. Our data suggest several viral and nonviral determinants of cervical HPV acquisition and clearance that might be used in cervical cancer prevention programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18974124      PMCID: PMC2727731          DOI: 10.1158/0008-5472.CAN-08-1380

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

Authors:  C B Woodman; S Collins; H Winter; A Bailey; J Ellis; P Prior; M Yates; T P Rollason; L S Young
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

3.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

4.  Epidemiology of HPV infection among Mexican women with normal cervical cytology.

Authors:  E Lazcano-Ponce; R Herrero; N Muñoz; A Cruz; K V Shah; P Alonso; P Hernández; J Salmerón; M Hernández
Journal:  Int J Cancer       Date:  2001-02-01       Impact factor: 7.396

5.  Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.

Authors:  M C Rousseau; J S Pereira; J C Prado; L L Villa; T E Rohan; E L Franco
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

6.  A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.

Authors:  K L Liaw; A Hildesheim; R D Burk; P Gravitt; S Wacholder; M M Manos; D R Scott; M E Sherman; R J Kurman; A G Glass; S M Anderson; M Schiffman
Journal:  J Infect Dis       Date:  2000-11-16       Impact factor: 5.226

7.  Determinants of genital human papillomavirus detection in a US population.

Authors:  C L Peyton; P E Gravitt; W C Hunt; R S Hundley; M Zhao; R J Apple; C M Wheeler
Journal:  J Infect Dis       Date:  2001-05-09       Impact factor: 5.226

8.  Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

9.  Human papillomavirus and the long-term risk of cervical neoplasia.

Authors:  Yolanda van der Graaf; Anco Molijn; Heleen Doornewaard; Wim Quint; Leen-Jan van Doorn; Jan van den Tweel
Journal:  Am J Epidemiol       Date:  2002-07-15       Impact factor: 4.897

10.  Prevalence and determinants of HPV infection among Colombian women with normal cytology.

Authors:  M Molano; H Posso; E Weiderpass; A J C van den Brule; M Ronderos; S Franceschi; C J L M Meijer; A Arslan; N Munoz
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more
  58 in total

1.  Rates and determinants of incidence and clearance of cervical HPV genotypes among HIV-seropositive women in Pune, India.

Authors:  Arati Mane; Vikrant V Sahasrabuddhe; Amit Nirmalkar; Arun R Risbud; Seema Sahay; Ramesh A Bhosale; Sten H Vermund; Sanjay M Mehendale
Journal:  J Clin Virol       Date:  2016-10-28       Impact factor: 3.168

2.  Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age.

Authors:  Carolyn E Banister; Amy R Messersmith; Bo Cai; Lisa B Spiryda; Saundra H Glover; Lucia Pirisi; Kim E Creek
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

3.  Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study.

Authors:  Mark E Scott; Yurii B Shvetsov; Pamela J Thompson; Brenda Y Hernandez; Xuemei Zhu; Lynne R Wilkens; Jeffrey Killeen; Dien D Vo; Anna-Barbara Moscicki; Marc T Goodman
Journal:  Int J Cancer       Date:  2013-03-16       Impact factor: 7.396

4.  The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the anus and cervix: the Hawaii HPV cohort study.

Authors:  Marc T Goodman; Katharine McDuffie; Brenda Y Hernandez; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Jeffrey Killeen; Lori Kamemoto; Yurii B Shvetsov
Journal:  J Infect Dis       Date:  2010-12-20       Impact factor: 5.226

5.  Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  Int J Cancer       Date:  2012-02-28       Impact factor: 7.396

6.  Meta-analysis of human papillomavirus infection concordance.

Authors:  Paul L Reiter; William F Pendergraft; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-10       Impact factor: 4.254

7.  Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: results at recruitment.

Authors:  Massimo Confortini; Francesca Carozzi; Marco Zappa; Leonardo Ventura; Anna Iossa; Paola Cariaggi; Livia Brandigi; Mario Franchini; Francesco Mirri; Paolo Viacava; Aurora Scarfantoni; Daniela Bazzanti; Cristina Sani
Journal:  BMC Infect Dis       Date:  2010-06-07       Impact factor: 3.090

8.  Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Authors:  Jing Ye; Xiaodong Cheng; Xiaojing Chen; Feng Ye; Weiguo Lü; Xing Xie
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

Review 9.  Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.

Authors:  Anne F Rositch; Jill Koshiol; Michael G Hudgens; Hilda Razzaghi; Danielle M Backes; Jeanne M Pimenta; Eduardo L Franco; Charles Poole; Jennifer S Smith
Journal:  Int J Cancer       Date:  2012-10-11       Impact factor: 7.396

10.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.